The 60+ author thing always rang as BS and useless. I'm betting maybe 2 or 3 actually had anything more than minimal input and 50+ did nothing more than read it.
And you better believe in a capitalist health care system. Investors are the most important or as important as doctors and patients unfortunately. Now if the right investor wanted nwbo and doctors to jump. They would ask "how high".
When they finally get their data out, it will probably be a base hit or "C", definitely not a Grand Slam or "A+". Stock may climb a few bucks or spike 10 or 20 bucks and quickly settle in the mid single digits somewhere.
And the long process of an additional trial(s) will begin anew.
News 
Market Data 
Discover 
